Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): Study protocol
- Andrew W. Horne
- , Monika M. Skubisz
- , Ann Doust
- , W. Colin Duncan
- , Euan Wallace
- , Hilary O D Critchley
- , Terrance G. Johns
- , Jane E. Norman
- , Siladitya Bhattacharya
- , Jill Mollison
- , Michael Rassmusen
- , Stephen Tong
Research output: Contribution to journal › Article › peer-review
10
Link opens in a new tab
Citations
(Scopus)